Agnès Taillandier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Agnès Taillandier has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Sophie Lia-Baldini
Département de Génie Biologique, Institut Universitaire de Technologies du Limousin, 87000 Limoges, France
1 shared publication - Delphine Fauvert
Unité de pathologie cellulaire et génétique EA2493, Université de Versailles-Saint Quentin en Yvelines, 78035 Versailles, France
1 shared publication - Etienne Mornet
Unité de Pathologie Cellulaire et Génétique UPRES-EA2493, Faculté de Médecine Paris Ile de France Ouest PRES Universud Paris, University of Versailles Saint Quentin en Yvelines, Versailles, France
1 shared publication - Isabelle Brun-Heath
Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain
1 shared publication - Jean-Louis Serre
Unité de pathologie cellulaire et génétique EA2493, Université de Versailles-Saint Quentin en Yvelines, 78035 Versailles, France
1 shared publication - Linda Bellazi
Unité de pathologie cellulaire et génétique EA2493, Université de Versailles-Saint Quentin en Yvelines, 78035 Versailles, France
1 shared publication
Latest Publications
- Open Access
- 6 June 2009
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10 (1) , 51
Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles
Background: Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect. In order to determine the cause of our failure to detect a second mutation by sequencing in patients with mild HPP and carrying on a single heterozygous mutation, we tested the possible dominant effect of 35 mutations carried by these patients. Methods: We tested the mutations by site-directed mutagenesis. We also genotyped 8 exonic and intronic ALPL gene polymorphisms in the patients and in a control group in order to detect the possible existence of a recurrent intronic mild mutation. Results: We found that most of the tested mutations exhibit a dominant negative effect that may account for the mild HPP phenotype, and that for at least some of the patients, a second mutation in linkage disequilibrium with a particular haplotype could not be ruled out. Conclusion: Mild HPP results in part from compound heterozygosity for severe and moderate mutations, but also in a large part from heterozygous mutations with a dominant negative effect.
- 6 June 2009
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10 (1) , 51
Open AccessMild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles
Background: Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect. In order to determine the cause of our failure to detect a second mutation by sequencing in patients with mild HPP and carrying on a single heterozygous mutation, we tested the possible dominant effect of 35 mutations carried by these patients. Methods: We tested the mutations by site-directed mutagenesis. We also genotyped 8 exonic and intronic ALPL gene polymorphisms in the patients and in a control group in order to detect the possible existence of a recurrent intronic mild mutation. Results: We found that most of the tested mutations exhibit a dominant negative effect that may account for the mild HPP phenotype, and that for at least some of the patients, a second mutation in linkage disequilibrium with a particular haplotype could not be ruled out. Conclusion: Mild HPP results in part from compound heterozygosity for severe and moderate mutations, but also in a large part from heterozygous mutations with a dominant negative effect.